Jia‐Shiuan Ju

Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan

Ping‐Chih Hsu, Suey-Haur Lee, Li‐Chung Chiu et al. · Targeted Oncology · 2023 · 25 citations · Full text

Durvalumab as Consolidation Therapy in Post-Concurrent Chemoradiation (CCRT) in Unresectable Stage III Non-Small Cell Lung Cancer Patients: A Multicenter Observational Study

Chin‐Chou Wang, Li‐Chung Chiu, Jia‐Shiuan Ju et al. · Vaccines · 2021 · 24 citations · Full text

Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation

Chi‐Hsien Huang, Jia‐Shiuan Ju, Tzu‐Hsuan Chiu et al. · International Journal of Cancer · 2021 · 20 citations · Full text

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

Allen Chung‐Cheng Huang, Chi‐Hsien Huang, Jia‐Shiuan Ju et al. · Therapeutic Advances in Medical Oncology · 2021 · 19 citations · Full text

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Jia‐Shiuan Ju, Allen Chung‐Cheng Huang, Pi‐Hung Tung et al. · Scientific Reports · 2023 · 16 citations · Full text